Blood-derived exosomal quantities for synaptic biomarkers GAP43, neurogranin, SNAP25 and synaptotagmin 1 correlated with their CSF values and detected patients with preclinical AD 5 to 7 years before they developed cognitive impairment. This evidence concerns the gene NRGN and Alzheimer disease.